Literature DB >> 18279332

Characterization of the NleF effector protein from attaching and effacing bacterial pathogens.

Frank Echtenkamp1, Wanyin Deng, Mark E Wickham, Alejandra Vazquez, Jose L Puente, Ajitha Thanabalasuriar, Samantha Gruenheid, B Brett Finlay, Philip R Hardwidge.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) is a water- and food-borne pathogen that causes hemorrhagic colitis. EHEC uses a type III secretion system (T3SS) to translocate effector proteins that subvert host cell function. T3SS-substrates encoded outside of the locus of enterocyte effacement are important to E. coli pathogenesis. We discovered an EHEC secreted protein, NleF, encoded by z6020 in O-island 71 of E. coli EDL933 that we hypothesized to be a T3SS substrate. Experiments are presented that probe the function of NleF and its role in virulence. Immunoblotting of secreted and translocated proteins suggest that NleF is secreted by the T3SS and is translocated into host cells in vitro where it localizes to the host cytoplasm. Infection of HeLa cells with E. coli possessing or lacking nleF and transient expression of NleF-GFP via transfection did not reveal a significant role for NleF in several assays of bacterial adherence, host cytoskeletal remodeling, or host protein secretion. However, competitive coinfection of mice with Citrobacter rodentium strains possessing or lacking nleF suggested a contribution of NleF to bacterial colonization. Challenge of gnotobiotic piglets also revealed a role for NleF in colonization of the piglet colon and rectoanal junction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279332      PMCID: PMC2657846          DOI: 10.1111/j.1574-6968.2008.01088.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  28 in total

Review 1.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 2.  Type III protein secretion systems in bacterial pathogens of animals and plants.

Authors:  C J Hueck
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

3.  A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.

Authors:  T K McDaniel; K G Jarvis; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection.

Authors:  S Tzipori; F Gunzer; M S Donnenberg; L de Montigny; J B Kaper; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells.

Authors:  M L McKee; A R Melton-Celsa; R A Moxley; D H Francis; A D O'Brien
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium.

Authors:  Michelle Kelly; Emily Hart; Rosanna Mundy; Olivier Marchès; Siouxsie Wiles; Luminita Badea; Shelley Luck; Marija Tauschek; Gad Frankel; Roy M Robins-Browne; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

7.  EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics.

Authors:  Sivan Dahan; Siouxsie Wiles; Roberto M La Ragione; Angus Best; Martin J Woodward; Mark P Stevens; Robert K Shaw; Yuwen Chong; Stuart Knutton; Alan Phillips; Gad Frankel
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

8.  Identification and characterization of EspK, a type III secreted effector protein of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  Isabella Vlisidou; Olivier Marchés; Francis Dziva; Rosanna Mundy; Gad Frankel; Mark P Stevens
Journal:  FEMS Microbiol Lett       Date:  2006-10       Impact factor: 2.742

9.  Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens.

Authors:  Olivier Marchés; Siouxsie Wiles; Francis Dziva; Roberto M La Ragione; Stephanie Schüller; Angus Best; Alan D Phillips; Elizabeth L Hartland; Martin J Woodward; Mark P Stevens; Gad Frankel
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

10.  An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination.

Authors:  Toru Tobe; Scott A Beatson; Hisaaki Taniguchi; Hiroyuki Abe; Christopher M Bailey; Amanda Fivian; Rasha Younis; Sophie Matthews; Olivier Marches; Gad Frankel; Tetsuya Hayashi; Mark J Pallen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-21       Impact factor: 11.205

View more
  16 in total

1.  Salmonella enteritidis Hcp distribute in the cytoplasm and regulate TNF signaling pathway in BHK-21 cells.

Authors:  Liming Zheng; Shenghua Wang; Mengyu Ling; Zhengmei Lv; Shuai Lin
Journal:  3 Biotech       Date:  2020-06-12       Impact factor: 2.406

2.  A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli.

Authors:  Víctor A García-Angulo; Verónica I Martínez-Santos; Tomás Villaseñor; Francisco J Santana; Alejandro Huerta-Saquero; Luary C Martínez; Rafael Jiménez; Cristina Lara-Ochoa; Juan Téllez-Sosa; Víctor H Bustamante; José L Puente
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

3.  The enterohemorrhagic Escherichia coli effector protein NleF binds mammalian Tmp21.

Authors:  Rachel L Olsen; Frank Echtenkamp; Dilyara Cheranova; Wanyin Deng; B Brett Finlay; Philip R Hardwidge
Journal:  Vet Microbiol       Date:  2013-02-04       Impact factor: 3.293

4.  Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli.

Authors:  Georgina L Pollock; Clare V L Oates; Cristina Giogha; Tania Wong Fok Lung; Sze Ying Ong; Jaclyn S Pearson; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

5.  Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells.

Authors:  Amin Tahoun; Gabriella Siszler; Kevin Spears; Sean McAteer; Jai Tree; Edith Paxton; Trudi L Gillespie; Isabel Martinez-Argudo; Mark A Jepson; Darren J Shaw; Manfred Koegl; Juergen Haas; David L Gally; Arvind Mahajan
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

6.  The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.

Authors:  Mitchell A Pallett; Cedric N Berger; Jaclyn S Pearson; Elizabeth L Hartland; Gad Frankel
Journal:  Infect Immun       Date:  2014-09-02       Impact factor: 3.441

7.  Expression and regulation of the Escherichia coli O157:H7 effector proteins NleH1 and NleH2.

Authors:  Ashleigh Holmes; Cecilia S Lindestam Arlehamn; Dai Wang; Tim J Mitchell; Tom J Evans; Andrew J Roe
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

8.  Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.

Authors:  Xiaofei Gao; Fengyi Wan; Kristina Mateo; Eduardo Callegari; Dan Wang; Wanyin Deng; Jose Puente; Feng Li; Michael S Chaussee; B Brett Finlay; Michael J Lenardo; Philip R Hardwidge
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

Review 9.  Enterohemorrhagic E. coli (EHEC) pathogenesis.

Authors:  Y Nguyen; Vanessa Sperandio
Journal:  Front Cell Infect Microbiol       Date:  2012-07-12       Impact factor: 5.293

10.  The E. coli effector protein NleF is a caspase inhibitor.

Authors:  Sonja Blasche; Mario Mörtl; Holger Steuber; Gabriella Siszler; Shahista Nisa; Frank Schwarz; Inna Lavrik; Thomas M A Gronewold; Klaus Maskos; Michael S Donnenberg; Dirk Ullmann; Peter Uetz; Manfred Kögl
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.